Dept. of the Army -- USAMRAA logo

DoW Lung Cancer Patient-Centered Outcomes and Survivorship Award

Dept. of the Army -- USAMRAA

Funding Amount

$1,950,000 total

Deadline

September 2, 2026

92 days left

Grant Type

federal

Overview

DoW Lung Cancer Patient-Centered Outcomes and Survivorship Award

Summary: The fiscal year 2026 (FY26) Lung Cancer Research Program (LCRP) Patient-Centered Outcomes and Survivorship Award (PCOSA) promotes evidence-based and patient-centered approaches to improve health and lung cancer related outcomes and enhance the patient experience in defined populations. Research must address at least one of the FY26 LCRP areas of emphasis in the Health Outcomes and Survivorship category. Distinctive Features: • This funding mechanism requires the research team to include an advocate who is a lung cancer patient/survivor or caregiver. • This funding mechanism allows proposed projects to include translational or clinical research, including pilot clinical trials.

Details

  • Agency: Dept. of the Army -- USAMRAA
  • Department: Department of Defense
  • Opportunity #: HT942526LCRPPCOSA
  • Total Funding: $1,950,000
  • Expected Awards: 2
  • Instrument: grant

Eligibility

Eligible Applicant Types

unrestricted

Focus Areas & Funding Uses

Fields of Work

science-researchcancer

Categories

Browse similar grants by category

Related Grants

Similar grants from this funder and related organizations

Ready to apply for DoW Lung Cancer Patient-Centered Outcomes and Survivorship Award?

Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.

You found DoW Lung Cancer Patient-Centered Outcomes and Survivorship Award. Now let's win it.

Start writing